Predictors of vision‐related quality of life in patients with macular oedema receiving intra‐vitreal anti‐VEGF treatment

Purpose To determine which demographic and clinical characteristics are predictive of vision‐related quality of life (VrQoL) and quality of life (QoL) in patients with macular oedema receiving intravitreal anti‐vascular endothelial growth factor (VEGF) treatment. Methods Vision‐related quality of li...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmic & physiological optics 2022-07, Vol.42 (4), p.849-857
Hauptverfasser:	Rausch‐Koster, Petra T., Rennert, Katharina N., Heymans, Martijn W., Verbraak, Frank D., Rens, Ger H. M. B., Nispen, Ruth M. A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acuity Decision making Demography Edema Eye intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) Item response theory macular oedema Original Patients Prediction models Quality of Life Risk assessment Sex Vascular endothelial growth factor Vision Vision‐related Quality of Life
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Purpose To determine which demographic and clinical characteristics are predictive of vision‐related quality of life (VrQoL) and quality of life (QoL) in patients with macular oedema receiving intravitreal anti‐vascular endothelial growth factor (VEGF) treatment. Methods Vision‐related quality of life (VrQoL) and quality of life (QoL) were measured in 712 patients with retinal exudative disease receiving anti‐VEGF treatment at baseline, 6 and 12 months. VrQoL was measured using an item‐response theory based 47‐question item bank (EyeQ), whereas QoL was measured using the EuroQol Five Dimensions (EQ‐5D) questionnaire. The EQ‐5D score was dichotomized into a perfect score of 1 and a suboptimal score of
ISSN:	0275-5408 1475-1313
DOI:	10.1111/opo.12984